+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ablynx - logo

Ablynx NV, a biopharmaceutical company, develops Nanobodies that is a proprietary therapeutic protein based on single-domain antibody fragments for the treatment of various diseases. The company develops products in various therapeutic areas, such as inflammation, hematology, oncology, and respiratory diseases. The company was formerly known as MatchX and changed its name to Ablynx NV in June 2002. Ablynx NV was founded in 2001 and is headquartered in Ghent, Belgium.

Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 51 Pages
  • Global
From
Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of End User and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of End User and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • January 2022
  • 242 Pages
  • Global
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

  • Report
  • April 2020
  • 536 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 500 Pages +
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 700 Pages
  • Global
From
Global Bispecific Antibody Market Opportunity, Drug Sales, Price & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Bispecific Antibody Market Opportunity, Drug Sales, Price & Clinical Trials Insight 2028

  • Report
  • August 2022
  • 600 Pages
  • Global
From
Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

  • Report
  • January 2020
  • 410 Pages
  • Global
From
Osteoporosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 375 Pages
  • Global
From
Nebulizers - Medical Devices Pipeline Product Landscape, 2021 - Product Thumbnail Image

Nebulizers - Medical Devices Pipeline Product Landscape, 2021

  • Report
  • March 2021
  • 50 Pages
  • Global
From
Nebulizer Systems Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update - Product Thumbnail Image

Nebulizer Systems Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • Report
  • July 2023
  • 68 Pages
  • Global
From
Thrombocytopenia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Thrombocytopenia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 225 Pages
  • Global
From
Bone Metastases - Pipeline Insight, 2024 - Product Thumbnail Image

Bone Metastases - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Thrombotic thrombocytopenic purpura - Pipeline Insight, 2024 - Product Thumbnail Image

Thrombotic thrombocytopenic purpura - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Immunology Drugs Market Report Suite for the United States - 2018-2024 - Product Thumbnail Image

Immunology Drugs Market Report Suite for the United States - 2018-2024

  • Report
  • April 2018
  • United States
From
Respiratory Syncytial Virus Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Respiratory Syncytial Virus Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 108 Pages
  • Global
From
US Thrombotic Thrombocytopenic Purpura (TTP) Market Insight, Epidemiology and Market Forecast -2030 - Product Thumbnail Image

US Thrombotic Thrombocytopenic Purpura (TTP) Market Insight, Epidemiology and Market Forecast -2030

  • Report
  • October 2021
  • 110 Pages
  • United States
From
Human Respiratory Syncytial Virus Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Human Respiratory Syncytial Virus Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • May 2023
  • 92 Pages
  • Global
From
Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028 - Product Thumbnail Image

Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028

  • Report
  • October 2021
  • 78 Pages
  • Global
From
Global Proteomics Partnering Terms and Agreements 2010 to 2023 - Product Thumbnail Image

Global Proteomics Partnering Terms and Agreements 2010 to 2023

  • Report
  • June 2023
  • 400 Pages
  • Global
From
Bone Metastasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bone Metastasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 98 Pages
  • Global
From
Loading Indicator